Intravitreal PRN ranibizumab treatment for macular edema due to branch retinal vein occlusion

Creative Commons License

ÇAKMAK H. B., Arikan Yorgun M., TOKLU Y., Mutlu M.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.47, no.1, pp.40-46, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 47 Issue: 1
  • Publication Date: 2017
  • Doi Number: 10.3906/sag-1509-39
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.40-46
  • Hacettepe University Affiliated: Yes

Abstract

Background/aim: To evaluate the effect of intravitreal pro re nata (PRN) ranibizumab treatment from the start on the best-corrected visual acuity (BCVA) and the central retinal thickness (CRT) in macular edema (ME) due to branch retinal vein occlusion (BRVO).